摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N(1)-苄基-3-甲基吡啶氯化物 | 16214-99-6

中文名称
N(1)-苄基-3-甲基吡啶氯化物
中文别名
——
英文名称
N-benzyl-3-methyl-pyridinium chloride
英文别名
1-benzyl-3-picolinium chloride;1-benzyl-3-methyl-pyridinium; chloride;1-Benzyl-3-methyl-pyridinium; Chlorid;1-benzyl-3-methyl-pyridinium chloride;Benzyl-3-methylpyridinium chloride;1-benzyl-3-methylpyridin-1-ium;chloride
N(1)-苄基-3-甲基吡啶氯化物化学式
CAS
16214-99-6
化学式
C13H14N*Cl
mdl
——
分子量
219.714
InChiKey
ZTRFNCRMTSVCAY-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.67
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    3.9
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:441f4cc9029f87bfbb376920b107f0e3
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Tsuda et al., Pharmaceutical Bulletin, 1953, vol. 1, p. 307,316
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-甲基吡啶氯化苄 反应 2.0h, 以100%的产率得到N(1)-苄基-3-甲基吡啶氯化物
    参考文献:
    名称:
    Synthesis of cis‐3‐methyl‐4‐aminopiperidine Derivatives
    摘要:
    A facile approach for the preparation of cis-3-methyl-4-aminopiperidine derivatives is described. The synthesis was carried out via regioselective ring opening of N-benzyl-3-methyl-3,4-epoxi-piperidine (8), which can be easily obtained in two steps from the corresponding N-benzyl-pyridinium salt (5). Seven new cis-3-methyl-4-amino and amido piperidines compounds were obtained.
    DOI:
    10.1080/00397910701865884
点击查看最新优质反应信息

文献信息

  • [DE] NEUE ALKIN-VERBINDUNGEN MIT MCH-ANTAGONISTISCHER WIRKUNG UND DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL<br/>[EN] NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS CONTAINING SAID COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES D'ALCYNE A EFFET ANTAGONISTE VIS-A-VIS DE MCH ET MEDICAMENTS CONTENANT CES COMPOSES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2005103031A1
    公开(公告)日:2005-11-03
    Die vorliegende Erfindung betrifft Alkin-Verbindungen der allgemeinen Formel I in der die Gruppen und Reste A, B, W, X, Y, Z, R1 und R2 die in Anspruch 1 angegebenen Bedeutungen aufweisen. Ferner betrifft die Erfindung Arzneimittel enthaltend mindestens ein erfindungsgemäßes Alkin. Auf Grund der MCH-Rezeptor antagonistischen Aktivität eignen sich die erfindungsgemäßen Arzneimittel zur Behandlung von metabolischen Störungen und/oder Essstörungen, insbesondere von Adipositas und Diabetes.
    This invention relates to alkyne compounds of general formula I in which the groups and residues A, B, W, X, Y, Z, R1, and R2 have the meanings specified in claim 1. Furthermore, the invention relates to pharmaceutical compositions containing at least one alkyne compound according to the invention. Due to the MCH receptor antagonistic activity, the pharmaceutical compositions of the present invention are suitable for the treatment of metabolic disorders and/or eating disorders, especially obesity and diabetes.
  • Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
    申请人:Stenkamp Dirk
    公开号:US20050239826A1
    公开(公告)日:2005-10-27
    The present invention relates to alkyne compounds of general formula I wherein the groups and radicals A, B, W, X, Y, Z, R 1 and R 2 have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one alkyne according to the invention. By virtue of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.
    本发明涉及通式I的炔化合物,其中基团和基团A、B、W、X、Y、Z、R1和R2具有权利要求1中给定的含义。此外,该发明涉及含有根据本发明的至少一种炔烃的药物组合物。由于其MCH受体拮抗活性,根据本发明的药物组合物适用于治疗代谢紊乱和/或进食障碍,特别是肥胖症和糖尿病。
  • An access to some functionalized azocine derivatives
    作者:Laurent Gil、Rossimiriam Pereira de Freitas Gil、Daniela Cristina dos Santos、Christian Marazano
    DOI:10.1016/s0040-4039(00)01008-x
    日期:2000.8
    The syntheses, from readily accessible 3-alkyl-4-methoxy-1,3,4,5-tetrahydropyridine 1, of functionalized 1,6,7,8-tetrahydroazocine 7 and 1,2,7,8-tetrahydroazocine 9 are reported.
    据报道,由易于获得的3-烷基-4-甲氧基-1,3,4,5-四氢吡啶1合成官能化的1,6,7,8-四氢偶氮cine碱7和1,2,7,8-四氢偶氮cine碱9。。
  • ——
    作者:G. V. Grishina、A. A. Borisenko、Z. G. Nosan'、I. S. Veselov、L. D. Ashkinadze、E. V. Karamov、G. V. Kornilaeva、N. S. Zefirov
    DOI:10.1023/a:1025307617288
    日期:——
  • Reaction of Aldimine Anions with Vinamidinium Chloride:  Three-Component Access to 3-Alkylpyridines and 3-Alkylpyridinium Salts and Access to 2-Alkyl Glutaconaldehyde Derivatives
    作者:Jean-Charles Wypych、Tuan Minh Nguyen、Michel Bénéchie、Christian Marazano
    DOI:10.1021/jo702311k
    日期:2008.2.1
    [GRAPHICS]N-tert-Butylimino derivatives of aldehydes were deprotonated with LDA and reacted with vinamidinium chloride to give 2-alkylaminopentadienimine derivatives, which were isolated as their corresponding hydrochloride in 68-81% yield. Reaction of these derivatives with ammonium acetate or salts of primary amines, in n-butanol at 80 degrees C, afforded the corresponding 3-alkylpyridines or 3-alkylpyridinium salts in high yield. Alkaline hydrolysis of 2-alkylaminopentadieneimine derivatives allowed a practical accesss to potassium salts of 2-alkylglutaconaldehyde.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-